Veru Inc VERU 深 滬
交易中 10-07 12:13:29 美东时间
2.505
+0.035
+1.42%
華盛通- 最 高2.505
- 今 開2.42
- 成交量 10.13万股
- 最 低 2.42
- 昨 收 2.47
- 總市值 4.27万
- 52周最高 7.33
- 市盈率 靜 --
- 換手率 0.59%
- 52周最低 2.05
- 委 比 41.77%
- 總股本 1.71万
- 歷史最高 245.70
- 量 比 0.68
- 振 幅 3.44%
- 歷史最低 2.05
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗看高AMD至800美元！富国上调Meta目标价至1000美元
今日重点评级关注：Jones Trading：维持Opus Genetics"买入"评级，目标价从10美元升至17美元；Citizens：维持Rezolute"跑赢大市"评级，目标价从11美元升至15美元
10-07 17:30
WestPark Capital Initiates Coverage On Veru with Buy Rating, Announces Price Target of $28
WestPark Capital analyst Ed Arce initiates coverage on Veru (NASDAQ:VERU) with a Buy rating and announces Price Target of $28.
10-07 01:52
Veru refocuses sabizabulin on post-daraxonrasib oncology
The latest announcement is out from Veru ( ($VERU) ). On September 8, 2026, Ver...
09-08 20:47
Veru shares are trading higher after the company reported better-than-expected Q3 EPS results.
Veru shares are trading higher after the company reported better-than-expected Q3 EPS results.
08-10 23:06
Veru Non-GAAP EPS of -$0.30 beats by $0.02
Veru press release (VERU): Q3 Non-GAAP EPS of -$0.30 beats by $0.02. Cash, cash equivalents and restricted cash were $23.9 million as of June 30, 2026 versus $15.8 million as of September 30, 202...
08-10 18:52
Veru Q3 EPS $(0.30) Beats $(0.32) Estimate
Veru (NASDAQ:VERU) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.32) by 6.25 percent. This is a 40 percent increase over losses of $(0.50) per share from the same period last year.
08-10 18:35
Veru Completes Patient Enrollment In Phase 2b PLATEAU Clinical Trial To Evaluate Effect Of Oral Enobosarm 3 Mg Versus To Treat Obesity
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the completion of enrollment in the Phase 2b PLATEAU clinical study to evaluate the effect of oral enob...
07-27 20:14
美股夜盘 | 柏雅国际涨41.30%，Advanced Biomed涨31.21%
Digital Brands Group, Inc.涨-20.24%；Ryde Group涨-12.83%；Psyence Biomedical Ltd.涨-9.12%
07-20 08:05
Veru Announces $21.8M Sales ATM Program With Oppenheimer, Canaccord
Veru Announces $21.8M Sales ATM Program With Oppenheimer, Canaccord
07-03 04:13
